Development of cisplatin-resistant cell lines

LY Li Yang
MS MingJing Shen
LX Li Jun Xu
XY Xiaodong Yang
YT Ying Tsai
PK Peter C. Keng
YC Yuhchyau Chen
SL Soo Ok Lee
request Request a Protocol
ask Ask a question
Favorite

Parental A549 (A549P) and H157 (H157P) cells were continuously treated with a gradually increased concentration of cisplatin for 6 months according to the method described by Barr et al.55. Briefly, cells were treated with 1 µM cisplatin for 72 hours and allowed to recover for the following 72 hours. After repeating one more cycle at 1 µM cisplatin concentration, the cells were then treated with 2 µM cisplatin in the following two cycles. This procedure was repeated with increasing cisplatin concentrations up to 30 µM. During the cisplatin-resistance induction procedure, the IC50 values of every 5 passages were determined in cisplatin-cytotoxicity tests and compared with those of the parental cells. The treatment continued until the increased IC50 value remained unchanged. The cisplatin-resistant cell lines obtained by this method were maintained in growth media containing 10 µM cisplatin.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A